InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Board Declares Special Cash Dividend
March 6, 2024
TRxADE Health (NASDAQ: MEDS), a parent company of pharmaceutical business-to-business (“B2B”) exchange platform, has announced a special cash dividend. According to the announcement, the company’s board of directors declared a cash dividend of $8 per share of common stock. “The special dividend is being paid using a portion of the proceeds from the closing of the […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Filing of Key Quarterly Report to Regain NASDAQ Exchange Compliance
January 18, 2024
TRxADE Health (NASDAQ: MEDS), a parent company of pharmaceutical business-to-business (“B2B”) exchange platform, has filed its quarterly report on Form 10-Q for the period ended Sept. 30, 2023. According to the announcement, the company received a standard notice of noncompliance from NASDAQ in November 2023. The notification indicated that the company was not in compliance with […]
InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Merger Partner Unveils Innovative Product It’s Bringing to Multibillion US Snacking Market
August 24, 2023
Superlatus Inc. recently merged with TRxADE Health (NASDAQ: MEDS) and is gearing up to revolutionize the snack industry. The company today unveiled its intent to introduce pulse-based twisted protein snacks through its Brave Robot brand. This innovation leverages the advanced food extrusion technology from its wholly owned subsidiary Sapientia Technology, LLC. By exploiting the combined […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Inks Acquisition Agreement with Perfect Day for Its Urgent Company, Consumer Brands Portfolio
August 22, 2023
TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider that recently merged with food technology and distribution company Superlatus Inc., announced an acquisition agreement. The company has entered a binding agreement with Perfect Day Inc. to acquire the Urgent Company Inc. along with its Coolhaus, Brave Robot, Modern Kitchen and California Performance Co. consumer brands. According to the announcement, the […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Files Extension for Form 10-Q Filing
August 14, 2023
TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider, has filed for an extension to file its quarterly report. The company filed the extension on Form 10-Q for the second quarter pursuant to a Form 12b-25 filed with the U.S. Securities and Exchange Commission (“SEC”). According to the announcement, TRxADE is “not able to timely file its […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Amended, Restates Superlatus Merger Agreement
July 17, 2023
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, released an amended and restated merger agreement with Superlatus Inc. Superlatus is a U.S.-based holding company of food products and distribution capabilities. According to the announcement, the […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS), Superlatus Expand Management Team
June 27, 2023
TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider, previously entered a binding letter of intent (“LOI”) to acquire Superlatus Inc., a U.S.-based holding company of food products and distribution capabilities. Subject to customary conditions, the merger was approved by the board of directors of both companies and is expected to close in the late […]
InvestorNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Inks MIPA in $10M NASDAQ Merger
June 26, 2023
Eat Well Group (CSE: EWG) (OTC: EWGFF), a leading plant-based food ingredient and CPG company, has entered into a definitive membership interest purchase agreement (“MIPA”) as part of a NASDAQ merger with TRxADE Health Inc. (NASDAQ: MEDS). The MIPA outlines the sale of Sapientia Technology Inc., EWGFF wholly-owned subsidiary, to Superlatus Inc. According to the Eat Well, […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS), Superlatus Inc. to Merge and Create a Global Food Consolidation Platform
June 23, 2023
TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider, has entered a binding letter of intent (the “LOI”) to acquire Superlatus Inc., a U.S.-based holding company of food products and distribution capabilities (the “merger”). Upon closing of the merger, Superlatus shareholders will receive 30,821,918 shares of MEDS, each valued at $7.30, and comprised of (i) […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Commences Trading After Board-Approved Reverse Stock Split
June 22, 2023
TRxADE Health (NASDAQ: MEDS) announced that its board of directors has approved a 1-for-15 reverse stock split of its common stock. The reverse stock split took effect at 11:59 p.m. Eastern Time on June 21, 2023, and is effective as of the opening of business on June 22, 2023. As a result, the company’s 10,210,878 […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q1 Financial Results
May 16, 2023
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting on its financial results for the quarter ended March 31, 2023. According to the report, the company is focused on continuing to expand its drug […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Upcoming Release of Q1 2023 Financial Results, Scheduled Earnings Call
May 8, 2023
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning to report on its financial results for first quarter 2023 after market close on May 15, 2023; the results will be made available in a […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Scheduled Release of Q1 2023 Financial Results, Conference Call
April 25, 2023
TRxADE Health (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company has announced that it will release its financial results for the first quarter 2023 after market close on May 8, 2023. In addition, […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q4, Year-End 2022 Financial and Corporate Report
March 28, 2023
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting its financial results for the year ending Dec. 31, 2022. Highlights of the report include consolidated revenues of $11.4 million, a 16.4% increase compared to […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Date for Release of Q4, Year-End 2022 Financial Report
March 14, 2023
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning to report on its financial results for fourth quarter and year-end 2022 on March 27, 2023. The company noted that the financial results will be […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Subsidiary Signs New Telemedicine Services Agreement
December 6, 2022
TRxADE Health (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, announced that Bonum Health, its digital healthcare business subsidiary, has signed a preferred telemedicine services agreement with an independent group purchasing organization. The agreement outlines significant discounts for group members to access Bonum Health’s service platform of more than 100 pharmacies in the northeastern part […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q3 Financial Numbers, Corporate Highlights
November 8, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting key results for quarter three 2022, which ended Sept. 30, 2022. As the company continues to expand its breakthrough digital care healthcare services IT platform […]
InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Bonum Health(TM) to Work with Insurance Brokers to Offer Telemedicine Services for SMB Employer Groups
October 26, 2022
TRxADE (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that Bonum Health, its digital health care subsidiary, has struck a strategic services distribution agreement with multiple insurance brokerage firms. As a result, the company, which offers nationwide telemedicine services for humans in all 50 states and pets in select states, […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Call to Discuss Upcoming 3Q Financial Results
October 25, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning to release corporate financial results for Q3 2022 next month. The company announced that it will release the information on Nov. 7, 2022, after market […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Enters into $1.8M Registered Direct Offering
October 5, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has entered into a securities purchase agreement with a single institutional investor. The agreement outlines the purchase of approximately $1.8 million of MEDS common stock, or prefunded […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Board Appointment of Leading Pharmaceutical Industry Expert
October 3, 2022
TRxADE (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company today announced the appointment of Jeff Newell to the company’s board of directors. A previous member of the company’s advisory board, Newell will serve […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Launches TRxADE Prime Plus to Meet Customers’ Needs of On-Demand Inventory
August 30, 2022
TRxADE (NASDAQ: MEDS), an integrated drug procurement, delivery and health care marketplace platform that connects buyers and sellers, today announced the launch of the Trxade Prime Plus program. Released in collaboration with the company’s pharmaceutical wholesale business subsidiary, Integra Pharma Solutions LLC (d/b/a TRxADE Prime), the program will allow member pharmacies better access to over […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Strategic Board Appointment of Leading Pharmaceutical Industry Expert
August 16, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the appointment of Jeff Newell to the company’s advisory board. Newell is expected to serve as a strategic resource to TRxADE as it continues […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q2 Financial Report Showing Revenue Growth
July 26, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its second-quarter 2022 financial and operational information, for the period ended June 30, 2022. According to the report, revenues for Q2 2022 increased 73%, totaling […]
InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Integra Pharma Partners with Pharmaceutical Co. to Help Network Members Succeed
July 13, 2022
TRxADE Health (NASDAQ: MEDS), through its wholly owned pharmaceutical wholesale business, Integra Pharma Solutions LLC, has inked a distribution agreement with GALT Pharmaceuticals LLC. Integra currently distributes generic and brand medications directly in 34 states through its warehouse; the new partnership adds single-source and multisource products directly from GALT Pharmaceuticals to its offering, supporting Integra’s mission […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Upcoming Earnings Call
July 12, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning on releasing its financial information for Q2 2022 after the market closes on July 25, 2022. The company announced that it will release the […]
InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Bonum Health Unveils Televeterinary Services
May 19, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has partnered with its digital healthcare subsidiary Bonum Health to announce a new service: televeterinary services for pets. According to the announcement, Bonum Health, which provides […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Q1 2022 Financial Numbers, Operational Highlights
May 10, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has released its first quarter 2022 financial results. Highlights of the report, which covers the period ended March 31, 2022, include revenues for the period totaling […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Plans to Release Q1 2022 Financial Numbers
April 25, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will release its financial results for first quarter 2022 on May 9, 2022; a press release with the financial report will be released after the market […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Release Fourth-Quarter, Year-End Financial Results
March 29, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its Q4 and fiscal year 2021 numbers. The company also reported operational highlights and noted that in 2022 it is continuing a strategic nationwide […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) to Release Fourth-Quarter, Year-End Financial Results
March 15, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced it will report its financial results for Q4 and year end 2021 later this month. The company said it will release the information on […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Subsidiary Partners with Grocery Chain to Provide Deeply Discounted Telemedicine to Uninsured, Underinsured Customers
February 23, 2022
TRxADE Group (NASDAQ: MEDS), an integrated drug procurement, delivery, healthcare platform and health service company, through its subsidiary Bonum Health, has signed a deal with Coborn’s Inc. for discount telemedicine services. TRxADE will work with Coborn’s, a regional grocery chain with more than 120 food and pharmacy grocery stores located throughout the Midwest, to provide affordable […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS), Exchange Health LLC Collaborate to Form SOSRx.com
February 15, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the formation with Exchange Health LLC of a joint venture, SOSRx LLC, a pharmaceutical platform. According to the update, SOSRx will provide pharmaceutical manufacturers […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Announces Participation in Aegis Virtual Conference
February 10, 2022
TRxADE Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be participating in the upcoming Aegis Capital Corp. Virtual Conference this month. The three-day conference is slated for Feb. 23–25, 2022. MEDS CEO Suren Ajjarapu […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Resumes Modified Stock Repurchase Program
December 13, 2021
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that its board of directors has authorized the resumption of the previously disclosed stock repurchase program, which the board modified to allow for the […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Launch of T-Rx(TM) Savings Card
November 30, 2021
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the launch of its TRxADE Discount Card. The new offering empowers independent pharmacies to continue providing their customers with deeply discounted drug pricing while […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) to Participate in Upcoming LD Micro Movers Virtual Event
November 18, 2021
TRxADE Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be presenting at the LD Micro Movers Virtual Event. The virtual event, which focuses on notable small-cap companies of 2021, will take place Dec. 1, 2021. […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Releases Q3 2021 Financial Report
October 26, 2021
TRxADE Group (NASDAQ: MEDS),a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its financial numbers for quarter three 2021, the period ended Sept. 30, 2021. Highlights of the report include a revenue increase of 34.3% over Q2 […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Planned Release of Q3 2021 Financial Results
October 11, 2021
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it will release financial results for the third quarter of 2021 after market close on Oct. 25, 2021. According to the update, management […]
InvestorNewsBreaks – TRxADE HEALTH INC.’s (NASDAQ: MEDS) Bonum Health Launches eGift Card Program
August 10, 2021
TRxADE HEALTH (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that its telehealth subsidiary, Bonum Health, has launched an electronic gift card program as an innovative new way for uninsured and under-insured consumers to gain access to health care. Bonum Health’s electronic gift cards (Bonum Health eGift(TM)) are pre-paid digital […]